source
- GSK discontinues its chronic cough therapy amid uncertain futureGSK has announced that it is ending development of its chronic cough treatment. The decision marks the conclusion of the program that had been under investigation for several years. The article do…
- Sonothera touts ultrasound gene-delivery platform for Duchenne, but experts remain skepticalSonothera, a California startup, says its ultrasound‑based technology can deliver therapeutic genes into cells, a method it believes could treat Duchenne muscular dystrophy and other genetic disord…